📰 Nasdaq Cgem News
Page 3 - Nasdaq Cgem News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Cgem. Real-time updates on events, politics, business and more.
September 1, 2022
CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that the compensation committee...
July 1, 2022
CAMBRIDGE, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that the compensation committee...
May 18, 2022
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Rating) – Research analysts at SVB Leerink raised their Q2 2022 earnings per share (EPS) estimates for shares of Cullinan Oncology in a report released on Monday, May 16th. SVB Leerink analyst A. Berens now forecasts that the company will post earnings per share of $5.44 for the quarter, […]
May 17, 2022
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Rating) major shareholder Vision Scs F2 sold 35,158 shares of the business’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $11.23, for a total transaction of $394,824.34. Following the transaction, the insider now directly owns 1,305,873 shares in the company, […]
May 16, 2022
Cullinan Oncology (NASDAQ:CGEM – Get Rating) and BioNTech (NASDAQ:BNTX – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation. Volatility and Risk Cullinan Oncology has a beta of 0.22, indicating […]
April 8, 2022
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Rating)’s stock price gapped up prior to trading on Wednesday following insider buying activity. The stock had previously closed at $12.14, but opened at $12.76. Cullinan Oncology shares last traded at $12.54, with a volume of 4,066 shares trading hands. Specifically, major shareholder Bvf Partners L. P/Il purchased 276,000 […]
April 8, 2022
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Rating) gapped down prior to trading on Friday . The stock had previously closed at $12.12, but opened at $11.86. Cullinan Oncology shares last traded at $11.97, with a volume of 101 shares. A number of equities analysts have recently weighed in on CGEM shares. HC Wainwright cut their […]
March 22, 2022
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Rating) – Investment analysts at SVB Leerink upped their FY2026 EPS estimates for Cullinan Oncology in a research note issued to investors on Thursday, March 17th. SVB Leerink analyst A. Berens now expects that the company will post earnings per share of $2.82 for the year, up from their […]
March 19, 2022
Cullinan Oncology (NASDAQ:CGEM – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.74) earnings per share for the quarter, missing the consensus estimate of ($0.50) by ($0.24), MarketWatch Earnings reports. CGEM stock traded up $0.52 during midday trading on Friday, hitting $13.33. The stock had a trading volume of 726,025 shares, […]